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What is Chinese Medicine?
The new journal, Chinese Medicine (CM), is a peer-
reviewed, open access, international, interdisciplinary and
scholarly journal in Chinese medicine. CM aims to pro-
vide evidence-led force for the advancement of Chinese
medicine research. CM is the official journal of the Inter-
national Society for Chinese Medicine (ISCM) [1] with
academic support from leading research institutes as its
members and financial support from the Macao Founda-
tion of the Macao Special Administrative Region, China.
Chinese Medicine will serve as an unbiased and non-com-
mercial platform for publishing advanced Chinese medi-
cine research. An open access online version of CM is
published by BioMed Central (BMC) [2], a London-based
leading publisher of biomedical journals. ISCM also pub-
lishes a print version of CM.
CM publishes articles reporting valuable research with
general interest in any aspect of Chinese medicine, such as
basic research, clinical research, methodologies, theories
and diagnoses, materia medica, acupuncture and other
non-pharmacologic modalities of the Chinese medical
system. CM welcomes submission of papers on applica-
tion of Chinese medicine in disease prevention, treat-
ment/management, and rehabilitation. In addition to
biomedical research, CM also accepts reports on various
aspects of Chinese medicine research, including public
health, regulation, management, education, technical
translation, cultural exchange and internationalization.
Multidisciplinary and translational research reports are
also strongly encouraged. All research and review articles
must be peer-reviewed to ensure that the valuable knowl-
edge drawn from them is evidence-based, scientifically
justified and ethical. Peer-review is conducted by at least
two internationally recognized experts in the respective
fields. Our high calibre reviewers and editors will only
accept papers of high quality.
Why a new Chinese medicine journal?
To meet the demand
Since the 1990s, there has been a phenomenal growth of
interest in traditional medicine knowledge and practices,
which is evident in the increasing World Health Organiza-
tion (WHO) activities and publications, such as Global
Strategy for Traditional Medicine (2002–2005) [3].
Research activities in Chinese medicine, one of the most
used and best documented traditional medicines, have
been increasing tremendously worldwide as well. A large
portion of the research in Chinese medicine has been car-
ried out in Asia, particularly in China, Japan and Korea,
and reported in their native languages. As a result, cur-
rently available Chinese medicine literature published in
English language journals does not meet the growing
demand from the international scientific community for
easy access to research findings in this field. Moreover,
most Chinese medicine literature is scattered throughout
a wide range of scientific journals of which Chinese med-
icine is often not the main concern. This also hinders easy
access to Chinese medicine research. CM aims to fill this
gap and tackle the problems.
To advocate evidence-led Chinese medicine (ELCM)
Our concept of evidence-led Chinese medicine (ELCM) is
broader than that of evidence-based Chinese medicine
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(EBCM). We believe that the advancement, including
modernization and internationalization, of Chinese med-
icine should be led by evidence. Chinese medicine
research should gather new evidence which can be used to
break new grounds and/or to verify old traditions. For
fruitful research, ELCM should be: (1) inheriting without
dogmatic restriction; (2) innovating without random
deviation; and (3) reasoning for true understanding. Sim-
ilar opinion was echoed in the consensus reached at the
2004 ISCM International Expert Forum [4]. ELCM treats
all appropriate research methodologies and evidences
equally, irrespective of whether they are traditional or
modern, conventional or alternative, macroscopic (sys-
tems and/or subsystems) or microscopic (cellular and/or
molecular) as long as scientific rigour is upheld.
Chinese medicine is a treasure of the Chinese people, who
not only have been benefiting from its well-known clini-
cal effectiveness but also have been inspired by its ancient
wisdom. With a natural and holistic approach, in addition
to disease treatment, Chinese medicine does care about a
person's well-being. It restores and maintains the dynamic
balance of a person, and achieves a harmony between
human and nature. While Chinese medicine is based on a
holistic system that is inherently different from the mod-
ern biomedical sciences, its holistic theories and practices
are not contradictory to general principles of logic and sci-
ence. Chinese medicine sees all components of the whole
person (system) interact dynamically with one another to
maintain a balanced physiological state. Serious imbal-
ance results in a diseased state. Conventional investiga-
tions on isolated components and/or processes are
missing the big picture and therefore will not fully unlock
the scientific value of Chinese medicine. The situation had
remained unchanged until systems biology, omics and
related technologies, new approaches and methodologies
for scientific study of Chinese medicine began to emerge.
From the perspective of systems biology and omics, all
components in a living organism/system interact dynam-
ically to maintain homeostasis (i.e. balance or equilib-
rium), and serious deviations from homeostasis cause
diseases. This idea is in line with the holistic concept and
practices of Chinese medicine. Chinese medicine research
adopting the approaches and methodologies of systems
biology and omics as well as those from other relevant
fields, such as evidence-based medicine (EBM) and clini-
cal and molecular epidemiology, will generate macro-
scopic, microscopic and integrative macroscopic-
microscopic evidences for ELCM. Supported by an inter-
national community of active researchers in the relevant
fields, CM will advocate ELCM in order to help unlock the
scientific value of Chinese medicine.
Why submit your manuscript to Chinese 
Medicine?
To better serve its authors and readers, CM strives to
ensure that the best Chinese medicine research is pub-
lished, and read by the widest possible range of interna-
tional audience. Open access journals provide the best
solution. While it is true that most of the established and
printed journals are available online, access to an article
usually requires a journal subscription or a purchase of an
individual article. Due to the high costs of subscription
fees, many research groups or libraries around the world,
especially those in the developing countries, are cutting
down on the numbers of subscribed journals. This limits
the dissemination of research findings.
Supported by strong Editorial and Advisory Boards, and
working closely with BioMed Central, an open access pub-
lisher based in London, we make all articles published in
the journal totally free to anyone who has access to the
Internet. Moreover, unlike many other journals within the
BMC family where authors pay an article processing
charge (APC), CM pays the APC for all authors in full, so
that authors have no financial burden to publish articles.
Our authors retain the copyright for their work and are
free to email the articles to their colleagues, post them on
the Internet, grant anyone the right to reproduce and dis-
seminate them, provided that it is correctly cited and no
errors are introduced. Apart from being available online,
articles published in our journal are also archived perma-
nently in PubMed Central [5], the US National Library of
Medicine's repository of life science literature, and in
repositories at the University of Potsdam [6] in Germany,
at INIST [7] in France and in e-Depot [8], the National
Library of the Netherlands' digital archive of all electronic
publications. This means that articles published in CM
have high international visibility and accessibility, and are
tremendously citation friendly. Studies have also pro-
vided strong evidence that open access (OA) articles are
more immediately recognized and cited by peers, leading
to a quicker and higher number of citations [9-11].
The distinctive features of CM, provided by BioMed Cen-
tral and our editorial office, offer special advantages to our
authors, readers, the scientific and medical communities
and the general public. The efficient electronic publishing
process sustained by BioMed Central ensures easy online
submission and fast online peer review and publication.
Furthermore, there are no length restraints or figure limits
and large datasets are also accepted. Articles are published
immediately upon acceptance and soon after indexed by
PubMed and other major repositories, meaning that they
will be read and searched quickly and globally. Our edito-
rial office believes that the more important the submitted
articles (i.e. papers of great interest and high profile), thePublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
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more they deserve the best treatment: (1) fast, thorough,
fair peer reviews by the most appropriate referees; (2)
effective presentation and professional formatting of the
articles both on the web and in print; and (3) promotion
of the articles to all interested parties. In a speedy and pro-
fessional manner, the scientific value and potential
impact of all published articles in CM will be judged and
evaluated by the international scientific community.
Conclusion
Chinese Medicine is an exciting medium for fostering evi-
dence-led force for the advancement of Chinese medicine
by committing to professional excellence and open access
publishing. CM aims to promote the generation of a
research knowledge base in Chinese medicine. CM is
devoted to bridging the gap between traditional Chinese
medicine and modern medicine. CM will endeavour to
unlock the scientific value of Chinese medicine. We
believe that it is now high time for a renaissance of tradi-
tional Chinese medicine and that the success of this jour-
nal relies very much on its editors working in concert with
its reviewers and authors to keep publishing high quality
papers in ELCM. Please join us and help make this hap-
pen.
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